Concomitant use of antiretroviral therapy (ART), hormonal contraception, and isonicotinic acid hydrazide (isoniazid) for tuberculosis prevention is common among women of reproductive age who are living with HIV in sub‐Saharan… Click to show full abstract
Concomitant use of antiretroviral therapy (ART), hormonal contraception, and isonicotinic acid hydrazide (isoniazid) for tuberculosis prevention is common among women of reproductive age who are living with HIV in sub‐Saharan Africa. We estimated the effect of isoniazid on 6‐month pregnancy risk among Malawian women living with HIV in the Family Planning and Antiretroviral Therapy (FP‐ART) prospective cohort study, overall and among subgroups defined by ART regimen type and hormonal contraceptive method.
Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!